What is the AbCellera Biologics Inc (ABCL) price today?

The price of AbCellera Biologics Inc (ABCL) today is $3.43. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Trade on Pluang

One platform for all markets

Download

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/ABCL

Buy & Sell AbCellera Biologics Inc (ABCL) – AbCellera Biologics Inc Price Today

Overview Financials Technicals Analysis Corp Action About

24H

YTD

Aura AI Summary

ABCL trades at $3.41, up 0.59% with a bearish technical outlook despite recent earnings beats. The company shows severe financial strain with negative net margins of -194.88% and declining revenue from $485M in 2022 to $29M in 2024. Positive developments include Phase 2 clinical trial progress for ABCL635 and strong analyst support with 82% buy ratings. Cash reserves remain substantial at $626M, providing operational runway amid ongoing losses.

Investment outlook remains speculative given persistent losses and revenue contraction. The primary opportunity lies in successful drug development pipeline execution, while key risks include prolonged negative cash flow and failure to achieve commercial milestones. Current valuation metrics appear stretched relative to deteriorating fundamentals.

Read full analysis

Key Stats

Market Cap
$1.00B
Sector
Health
3M Drawdown
-40.09%
Enterprise Value
$611.34M
Dividend Yield
-
Trading Activity
84% Buy | 16% Sell
Typical Hold Time
39 days

$3.43

52W Low: $1.93

08 Apr 2025

52W High: $6.17

08 Oct 2025

AbCellera Biologics Inc (ABCL) is currently valued at a market capitalization of $1.00B, with an enterprise value of $611.34M. Over the past 52 weeks, AbCellera Biologics Inc has traded between a low of $1.93 and a high of $6.17, highlighting its annual price range. Over the past three months, AbCellera Biologics Inc has recorded a drawdown of -40.09%, reflecting recent price volatility. AbCellera Biologics Inc offers a dividend yield of -. On average, investors hold AbCellera Biologics Inc for approximately 39 days, indicating typical investor behavior on the platform.

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Technical Indicators

Overall Summary

Bearish (1)Neutral (6)Bullish (20)

News

Zacks Investment2 year ago

Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks Investment2 year ago

Analysts Estimate AbCellera Biologics Inc. (ABCL) to Report a Decline in Earnings: What to Look Out for

The Motley Fool2 year ago

AbCellera Biologics (ABCL) Q4 2023 Earnings Call Transcript

Zacks Investment2 year ago

AbCellera Biologics Inc. (ABCL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Investment2 year ago

Beyond Air, Inc. (XAIR) Reports Q3 Loss, Misses Revenue Estimates

People also bought

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

Market Cap
$1.00B
Sector
Health
3M Drawdown
-40.09%
Enterprise Value
$611.34M
Dividend Yield
-
Trading Activity
84% Buy | 16% Sell
Typical Hold Time
39 days

$3.43

52W Low: $1.93

08 Apr 2025

52W High: $6.17

08 Oct 2025

Let’s invest in this asset by signing up or download!

Buy & Sell AbCellera Biologics Inc (ABCL) – AbCellera Biologics Inc Price Today

Aura AI Summary

Key Stats

About AbCellera Biologics Inc

People also bought

Key Stats

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store